Valuation : BPH Global Ltd

Market Cap 3.53M 2.54M 2.19M 2.05M 1.88M 3.51M 240M 24.23M 9.44M 123M 9.54M 9.33M 396M P/E 2024
-0.35x
P/E 2025 -0.75x
Enterprise Value 3.38M 2.43M 2.09M 1.96M 1.8M 3.35M 230M 23.18M 9.03M 118M 9.13M 8.93M 379M EV / Sales 2024
11.9x
EV / Sales 2025 5.53x
Free-Float
89.66%
Yield 2024 *
-
Yield 2025 -
1 day-33.33%
1 week-33.33%
1 month-50.00%
3 months-50.00%
6 months-50.00%
Current year-50.00%
1 week 0
Extreme 0.001
0
1 month 0
Extreme 0.001
0
Current year 0
Extreme 0.001
0
1 year 0
Extreme 0.001
0
3 years 0
Extreme 0.001
0.02
5 years 0
Extreme 0.001
0.08
10 years 0
Extreme 0.001
5.42
Manager TitleAgeSince
Chief Executive Officer 55 2023-11-20
Chief Tech/Sci/R&D Officer - 2026-05-24
Corporate Secretary - 2024-04-10
Director TitleAgeSince
Chairman - 2026-06-21
Director/Board Member 55 2023-03-29
Director/Board Member - 2019-05-26
Change 5-day change 1-year change 3-year change Capi.($)
-33.33%-33.33%-50.00%-90.00% 1.69M
-0.24%-0.99%+3.26%+18.17% 50.14B
+0.78%-2.12%+433.44%+501.63% 44.85B
+2.95%+3.87%+47.83%+21.08% 43.43B
+0.25%-3.49%+9.23%+73.60% 41.14B
+0.43%-3.26%+14.75%+49.08% 32.92B
+1.43%+8.34% - - 17.56B
+0.06%-4.15%+25.36%+116.96% 16.55B
+0.93%+0.88%+19.64%+29.70% 14.65B
+0.54%-0.59%+81.92%+39.94% 13.93B
Average -2.62%-4.02%+65.05%+84.46% 27.52B
Weighted average by Cap. +0.81%-1.13%+94.69%+123.81%

Financials

2024 2025
Net sales 110K 79.18K 68.09K 63.94K 58.49K 109K 7.48M 755K 294K 3.83M 297K 291K 12.34M 352K 254K 218K 205K 187K 350K 23.97M 2.42M 943K 12.29M 953K 932K 39.54M
Net income -2.65M -1.91M -1.64M -1.54M -1.41M -2.63M -180M -18.2M -7.09M -92.45M -7.17M -7.01M -298M -1.49M -1.07M -920K -864K -791K -1.48M -101M -10.2M -3.98M -51.83M -4.02M -3.93M -167M
Net Debt 119K 86.05K 73.99K 69.49K 63.56K 119K 8.13M 820K 320K 4.17M 323K 316K 13.41M -153K -110K -94.58K -88.82K -81.24K -152K -10.39M -1.05M -409K -5.33M -413K -404K -17.14M
Logo BPH Global Ltd
BPH Global Limited is an Australia-based plant-focused biotechnology company. The Company is focused on producing foods, health and cosmetic products which deliver Traditional Chinese Medicine (TCM)-based health outcomes. It focuses on the research and development, production and commercialization of TCM products, including raw bird’s nest and processed bird’s nest products, raw seaweed and sea plants as sustainable plant-based protein foods and nutraceutical and pharmaceutical ingredients extracted from seaweed and sea plants for utilization in the food, nutrition, healthcare, health supplements, cosmetics and personal care industries. The Company’s product focus is on raw bird’s nests; higher end processed bird’s nest products; and Sea Grapes (Caulerpa Lentillifera) and seaweeds. Its subsidiaries include Hainan SCU Biotechnology Co Ltd, Foshan Gedishi Biotechnology Co Ltd, SCU Lab Pty Ltd, PT BPH Global Indonesia, Stemcell United Pte Ltd and others.
Employees
31
Date Price Change Volume
26-08-31 A$0.001000 -33.33% 2,785